The WHO criteria specifies either T2DM or IR/IGT, plus 2 of either raised blood pressure (>140/90), dyslipidaemia (triglycerides [TG] >1.695 mmol/liter and high-density lipoprotein (HDL) < 0.9 mmol/l), central obesity (waist:hip ratio >0.90 or body mass index [BMI] >30 kg/m2), and microalbuminuria (urinary albumin excretion ratio >20 μg/min or albumin:creatinine ratio > 30 mg/mmol). This evidence concerns the gene ALB and type 2 diabetes mellitus.